ABSCI CORP Basic Shares Outstanding (Weighted Average)
ABSCI CORP (ABSI) reported Basic Shares Outstanding (Weighted Average) of 157.47 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- ABSCI CORP weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 157.47M shares, a 23.42% increase year-over-year.
- ABSCI CORP weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 152.96M shares, a 22.90% increase year-over-year.
- ABSCI CORP weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 150.76M shares, a 31.14% increase year-over-year.
- ABSCI CORP weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 143.77M shares, a 26.54% increase year-over-year.
- ABSCI CORP weighted average number of shares outstanding, basic for fiscal 2025 was 136.78M shares, a 24.07% increase from fiscal 2024.
- ABSCI CORP weighted average number of shares outstanding, basic for fiscal 2024 was 110.24M shares, a 19.79% increase from fiscal 2023.
- ABSCI CORP weighted average number of shares outstanding, basic for fiscal 2023 was 92.03M shares, a 1.30% increase from fiscal 2022.
- ABSCI CORP weighted average number of shares outstanding, basic for fiscal 2022 was 90.85M shares, a 82.84% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 157.47M shares 10-Q · filed 2026-08-11 | 155.22M shares 10-Q · filed 2026-08-11 | 153.73M shares derived: average of 3 quarters · filed 2026-08-11 | 151.24M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 152.96M shares 10-Q · filed 2026-05-07 | 151.86M shares derived: average of 2 quarters · filed 2026-05-07 | 149.16M shares derived: average of 3 quarters · filed 2026-05-07 | 143.77M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 150.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 147.27M shares derived: average of 2 quarters · filed 2026-03-24 | 140.71M shares derived: average of 3 quarters · filed 2026-08-11 | 136.78M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 143.77M shares 10-Q · filed 2025-11-12 | 135.68M shares derived: average of 2 quarters · filed 2026-08-11 | 132.11M shares 10-Q · filed 2025-11-12 | 127.70M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 127.59M shares 10-Q · filed 2026-08-11 | 126.04M shares 10-Q · filed 2026-08-11 | 122.34M shares derived: average of 3 quarters · filed 2026-08-11 | 120.16M shares derived: average of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 124.46M shares 10-Q · filed 2026-05-07 | 119.71M shares derived: average of 2 quarters · filed 2026-05-07 | 117.68M shares derived: average of 3 quarters · filed 2026-05-07 | 116.49M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 114.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 114.29M shares derived: average of 2 quarters · filed 2026-03-24 | 113.84M shares derived: average of 3 quarters · filed 2026-03-24 | 110.24M shares 10-K · filed 2026-03-24 |
| 2024-09-30 | 113.61M shares 10-Q · filed 2025-11-12 | 113.27M shares derived: average of 2 quarters · filed 2025-11-12 | 108.67M shares 10-Q · filed 2025-11-12 | 104.63M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 112.93M shares 10-Q · filed 2025-08-12 | 106.16M shares 10-Q · filed 2025-08-12 | 101.64M shares derived: average of 3 quarters · filed 2025-08-12 | 99.28M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 99.39M shares 10-Q · filed 2025-05-13 | 95.99M shares derived: average of 2 quarters · filed 2025-05-13 | 94.73M shares derived: average of 3 quarters · filed 2025-05-13 | 94.00M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 92.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 92.40M shares derived: average of 2 quarters · filed 2025-03-18 | 92.21M shares derived: average of 3 quarters · filed 2025-03-18 | 92.03M shares 10-K · filed 2025-03-18 |
| 2023-09-30 | 92.22M shares 10-Q · filed 2024-11-12 | 92.02M shares derived: average of 2 quarters · filed 2024-11-12 | 91.84M shares 10-Q · filed 2024-11-12 | 91.71M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 91.83M shares 10-Q · filed 2024-08-14 | 91.65M shares 10-Q · filed 2024-08-14 | 91.54M shares derived: average of 3 quarters · filed 2024-08-14 | 91.43M shares derived: average of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 91.48M shares 10-Q · filed 2024-05-14 | 91.40M shares derived: average of 2 quarters · filed 2024-05-14 | 91.30M shares derived: average of 3 quarters · filed 2024-05-14 | 91.14M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 91.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 91.21M shares derived: average of 2 quarters · filed 2024-03-21 | 91.03M shares derived: average of 3 quarters · filed 2024-03-21 | 90.85M shares 10-K · filed 2024-03-21 |
| 2022-09-30 | 91.11M shares 10-Q · filed 2023-11-14 | 90.89M shares derived: average of 2 quarters · filed 2023-11-14 | 90.69M shares 10-Q · filed 2023-11-14 | 90.56M shares derived: average of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | 90.67M shares 10-Q · filed 2023-08-14 | 90.47M shares 10-Q · filed 2023-08-14 | 90.38M shares derived: average of 3 quarters · filed 2023-08-14 | 86.11M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 90.27M shares 10-Q · filed 2023-05-15 | 90.24M shares derived: average of 2 quarters · filed 2023-05-15 | 84.59M shares derived: average of 3 quarters · filed 2023-05-15 | 67.85M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 90.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 81.75M shares derived: average of 2 quarters · filed 2023-03-30 | 60.38M shares derived: average of 3 quarters · filed 2023-03-30 | 49.69M shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 73.29M shares 10-Q · filed 2022-11-09 | 45.47M shares derived: average of 2 quarters · filed 2022-11-09 | 36.18M shares 10-Q · filed 2022-11-09 | 31.06M shares derived: average of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 17.64M shares 10-Q · filed 2022-08-11 | 17.31M shares 10-Q · filed 2022-08-11 | 16.98M shares derived: average of 3 quarters · filed 2022-08-11 | 16.54M shares derived: average of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | 16.98M shares 10-Q · filed 2022-05-11 | 16.66M shares derived: average of 2 quarters · filed 2022-05-11 | 16.18M shares derived: average of 3 quarters · filed 2022-05-11 | 15.94M shares derived: average of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | 16.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 15.77M shares derived: average of 2 quarters · filed 2022-03-22 | 15.59M shares derived: average of 3 quarters · filed 2022-03-22 | 15.49M shares 10-K · filed 2022-03-22 |
| 2020-09-30 | 15.22M shares 10-Q · filed 2021-11-09 | 15.22M shares derived: average of 2 quarters · filed 2021-11-09 | 15.22M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 15.22M shares 10-Q · filed 2021-09-07 | 15.22M shares 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |